Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Keiko who wrote (8279)	2/27/1998 11:35:00 AM
From: Grainne	Respond to of 14328

Thank you, Keiko, for your compliment about my name (I would rather be rich from my Trinity Biotech stock and have an ugly one, though, because at least I could change my name). I have followed this whole thread since its inception, and have never been able to figure out why this company's growth has not been reflected in its share price. While I would agree that chasing a stock is stupid, and part of that great learning experience about investing that we all get sooner or later, it still will ultimately work if the price is relatively cheap, and the company is a good one, and you have patience. Certainly, buying Trinity at $5.00 still seemed like a bargain to many people, looking at the management and the potential and the wads of cash they held. I am as puzzled as you are as to why it continues to hang around two dollars. Sometimes this means that there is bad news somewhere in the company or the industry, that the market knows, being all wise, and the investors do not. I hope not! Anyway, thank you very much for your comments, Keiko. Christine